Calibre One, a leading global executive search boutique specializing in building leadership teams for innovators, entrepreneurs and companies undergoing technology or digital transformation, announces its new Boston location. Molly A. Robb, who will head this new northeast office, has been added as partner specializing in the company’s healthcare and life sciences practice working closely with Christos Richards who leads the practice from the west coast.
“We’re very happy to have Molly join our Calibre One family and to spearhead our newest East Coast presence in the beautiful and historic city of Boston,” said Tom Barnes, managing partner. “Between Molly and Christos’ top-notch skills and experience in placing healthcare and life sciences CEOs, C-suite and board professionals, we have truly created a bicoastal dream team. And Molly’s additional expertise in the healthcare investment sector will be instrumental in adding value to our already successful healthcare and life sciences practice.”
A twenty-year executive recruiting professional, Robb has worked with leading venture capital and private equity firms in helping place board, CEO and C-suite positions into life sciences organizations that compete in biotechnology, pharmaceutical, medical devices, diagnostics/tools and digital health/healthtech. She serves clients ranging from early-stage, emerging growth and public companies as well as private equity and venture capital funds making investments into companies focusing on innovation in oncology, Alzheimer’s Disease, neurodegenerative diseases, rare diseases and cell and gene therapy.
Prior to Calibre One, Robb was a managing director with BioQuest, part of The Diversified Search Group, working in both the life sciences sector recruiting senior-level operating leaders and as a member of the financial services practice where she recruited healthcare investors into public and private capital investment funds. Additionally, she has worked at Heidrick and Struggles in the healthcare private equity and venture capital practice and with Korn Ferry International in its life sciences practice.
Robb is an avid supporter for the Alzheimer’s Drug Discovery Foundation (ADDF), a regular speaker and frequent webinar presenter on career management for the Wharton Healthcare Management Alumni Association and has volunteered as a business mentor for C-Sweetener (part of HLTH Foundation), a mentoring organization that prepares women leaders for the healthcare C-suite. After a family member’s diagnosis of Bietti’s Crystalline Dystrophy (BCD), a rare, genetic eye disease that causes blindness for 100,000 people globally, Robb volunteers as a strategic advisor to Invincible Vision, a patient-led, nonprofit organization focused on serving the global BCD community.
She holds a bachelor’s degree in journalism from the University of Wisconsin-Madison with a double emphasis on advertising and mass communications.